MTOR and diabetic kidney disease: It is well documented that PI3K-Akt-mammalian target of rapamycin (mTOR) signaling pathway plays a key role in matrix protein synthesis during diabetic kidney disease [7], since blockade of this pathway ameliorates renal injury in diabetic rodent models [192].